Item 6. SELECTED FINANCIAL DATA

9K characters. Original on sec.gov · Markdown

Item 6. SELECTED FINANCIAL DATA

This table sets forth selected financial data of Lumentum (in millions, except share and per share amounts) for the periods indicated. This data should be read in conjunction with the discussion in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of this Annual Report and our audited consolidated financial statements included in Item 8 of this Annual Report. The selected data in this section are not intended to replace the Consolidated Financial Statements included in this Annual Report.

Years Ended
July 3, 2021 (1)June 27, 2020 (2)June 29, 2019 (3)June 30, 2018 (4)July 1, 2017 (5)
Consolidated Statements of Operations Data:
Net revenue$1,742.8$1,678.6$1,565.3$1,247.7$1,001.6
Gross profit783.1650.2425.9432.1318.1
Income (loss) from operations527.0204.1(21.6)139.947.6
Net income (loss)397.3135.5(36.4)248.1(102.5)
Cumulative dividends on Series A Preferred Stock——(0.3)(0.9)(0.9)
Earnings allocated to Series A Preferred Stock——(1.2)(5.7)—
Net income (loss) attributable to common stockholders$397.3$135.5$(37.9)$241.5$(103.4)
Net income (loss) per share attributable to common stockholders:
Basic$5.27$1.79$(0.54)$3.88$(1.71)
Diluted$5.07$1.75$(0.54)$3.82$(1.71)
Shares used to compute net income (loss) per share attributable to common stockholders:
Basic75.475.970.762.360.6
Diluted78.477.670.763.360.6
Balance as of
July 3, 2021 (1)June 27, 2020 (2)June 29, 2019 (3)June 30, 2018 (4)July 1, 2017 (5)
Consolidated Balance Sheet Data:
Cash and cash equivalents$774.3$298.0$432.6$397.3$272.9
Short-term investments1,171.71,255.8335.9314.2282.4
Total assets3,551.63,292.62,716.61,581.51,232.9
Convertible notes1,180.51,120.3351.9334.2317.5
Term loan, non-current——484.0——
Derivative liability———52.451.6
Other non-current liabilities40.936.033.719.025.0
Total redeemable convertible preferred stock———35.835.8
Total stockholders’ equity1,972.81,749.21,497.1926.1618.8

(1)On January 18, 2021, we entered into a merger agreement with Coherent, under which we would acquire all outstanding shares of Coherent common stock. In March 2021, Coherent terminated the merger agreement and paid us a termination fee of $217.6 million in accordance with the merger agreement. This gain was offset by $10.1 million of acquisition related expenses and the net amount is presented as “Merger termination fee and related costs, net” in our Consolidated Statement of Operations for the year ended July 3, 2021.

On May 7, 2021, our board of directors approved the 2021 share buyback program, which authorizes us to use up to $700.0 million to purchase our own shares of common stock. The buyback program is authorized for 2 years but may be suspended or terminated by the board of directors at any time. In the fiscal fourth quarter of 2021, we repurchased 3.1 million shares of our common stock at an average price of $77.84 per share for an aggregate purchase price of $241.0 million. These shares were retired immediately.

(2)In fiscal 2020, we repaid, in full, all amounts outstanding under our Term Loan Facility. In December 2019, we issued $1,050.0 million of the 2026 Notes in a private offering. We used approximately $196 million of the net proceeds of the offering to repay in full all amounts outstanding under our term loan facility, and a portion of the net proceeds of the offering to purchase approximately $200 million of our common stock concurrently with the pricing of the offering in privately negotiated transactions.

(3)On December 10, 2018, we completed the acquisition of Oclaro, a provider of optical components and modules for the long-haul, metro and data center markets, for $1.4 billion, which was funded through the issuance of Lumentum common stock, new debt, and cash balances of the combined company. Refer to “Note 4. Business Combinations” in the notes to consolidated financial statements for further discussion of the merger. Results of operations and financial position of the business acquired have been included in our consolidated financial statements subsequent to the date of acquisition.

(4)During the second quarter of fiscal 2018, we had a credit of $207.0 million primarily related to a release of a U.S. valuation allowance, which was offset by a write-down of deferred tax assets in the amount of $83.0 million due to the lower corporate tax rate enacted under the 2017 “Tax Cuts and Jobs Act” reform.

(5)During the third quarter of fiscal 2017, we completed the acquisition of a privately held company. Results of operations and financial position of the business acquired have been included in our consolidated financial statements subsequent to the date of acquisition.

Previous: Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES · Next: Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS